BioSpace News Archive

BioCapital

CEL-SCI Issues Letter to Shareholders

CEL-SCI enters 2018 in a position of strength and hope for the year ahead.

January 3, 2018
·
8 min read
Intec Pharma Granted Patent in Canada for Accordion Pill Carbidopa / Levodopa

Intec Pharma today announced that the Canadian Intellectual Property Office has issued a Certificate of Grant of a Canadian patent No. 2,721,493.

January 3, 2018
·
4 min read
Business

Jacqueline Delfgaauw, Ph.D. Joins Analgesic Solutions as Executive Director, Clinical Science

Dr. Delfgaauw’s extensive experience in the clinical development of various products focused in pain will be a critical to Analgesic Solutions’ ongoing success and rapid expansion going forward.

January 3, 2018
·
1 min read
Business

Eiger BioPharma Appoints David Apelian, MD, PhD, MBA COO and Executive Medical Officer

Dr. Apelian was most recently Executive VP and CMO of Achillion, a position he held since 2013.

January 3, 2018
·
4 min read
Deals

NovaQuest Capital Management to Acquire Viamet Pharmaceuticals and the VT-1161 Antifungal Program

Upon closing of the acquisition, Viamet Pharmaceuticals will be a portfolio company of NovaQuest Capital, which will focus on further development of VT-1161 and related assets.

January 3, 2018
·
6 min read
Genetown

Synspira Announces $3 Million Development Award From Cystic Fibrosis Foundation

Synspira today announced that it has received up to a $3 million award from the Cystic Fibrosis (CF) Foundation to advance clinical development of its lead candidate, SNSP113, for use in pulmonary complications of cystic fibrosis (CF).

January 3, 2018
·
3 min read
Business

Boston Pharmaceuticals Appoints Dr. Peter Ho as Chief Medical Officer

Dr. Ho joins Boston Pharmaceuticals from Epizyme, where as Chief Medical Officer he led the company’s clinical development, translational medicine and regulatory affairs functions.

January 3, 2018
·
3 min read
Business

FLX Bio Appoints Dirk G. Brockstedt, Ph.D., as Senior Vice President of Biology

Dr. Brockstedt joins FLX Bio most recently from Aduro Biotech, where he served in a number of escalating positions, most recently as Executive Vice President of Research and Development.

January 3, 2018
·
3 min read
VolitionRx Limited Releases Letter to Shareholders Including Status Update on Key Clinical Milestone

In the letter, Mr. Reynolds outlines several significant accomplishments to date and highlights the fact that the company believes that it is close to achieving a key clinical milestone with the completion of a 680-subject trial for the Nu.Q Frontline Asymptomatic Colorectal Cancer Screening Test.

January 3, 2018
·
6 min read
Policy

PharmaMar Has Requested the Process of Re-Examination for Aplidin From the EMA

PharmaMar has announced the initiation of the re-examination process by the EMA for Aplidin for the indication of relapsed and refractory multiple myeloma.

January 3, 2018
·
1 min read